Business Wire

IQM Advances AI-Driven Agentic Calibration, Opening Quantum Computing to the Enterprise With NVIDIA Ising

14.4.2026 16:00:00 CEST | Business Wire | Press Release

Share

On World Quantum Day, IQM Quantum Computers today announced AI-driven agentic calibration, an automated approach to tuning quantum systems with NVIDIA Ising.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414522140/en/

Illustration of AI-driven agentic calibration

The development marks a step toward making quantum computing operationally viable for enterprises, AI factories, and high-performance computing data centres — reducing dependence on dedicated quantum engineering expertise and bringing quantum infrastructure within reach of institutions that need to own and operate it at scale.

The core architectural advance is parallelism. IQM's visual agents inspect calibration results across qubits simultaneously at each stage — not sequentially. As quantum processors scale, the number of interaction channels between qubits grows non-linearly. Sequential calibration cannot keep pace. Parallel agentic inspection can.

"We want enterprises to use quantum computers, not just study them. Calibration has always been the quiet bottleneck. If we can take that off the table, enterprises can focus on what they actually bought the machine for,” said Juha Vartiainen, Chief Global Affairs Officer and Co-founder of IQM Quantum Computers.

The operational barrier is compounded by a structural one. Quantum engineering talent is scarce globally, and demand is outpacing supply. Requiring on-site quantum specialists to maintain calibration is not a sustainable model for broad enterprise adoption. Agentic calibration addresses this directly — shifting the operational burden from human expertise to intelligent automation, and making quantum ownership viable for institutions that cannot recruit from a talent pool that barely exists yet.

As governments and enterprises race to build AI factories — integrated facilities combining classical HPC, accelerated computing, and increasingly, quantum processing — operational simplicity is not optional. A quantum system that requires resident specialists to stay calibrated is not factory-ready. IQM's agentic calibration is designed to change that.

IQM's implementation builds on NVIDIA Ising models, fine-tuned for quantum tasks — a key ingredient in the system's accuracy and reliability. The agentic calibration integrates AI agents directly into IQM's existing calibration infrastructure, augmenting rather than replacing the underlying system. The result is quantum computers that self-optimise, maintain higher algorithmic efficiency, and operate consistently at high fidelity — delivering accurate computational results faster.

"The next generation of supercomputers will be quantum-GPU systems, and AI is what makes them operable,” said Sam Stanwyck, Director of Quantum Product at NVIDIA. “NVIDIA Ising gives developers an open foundation to tackle quantum computing's hardest challenges, and IQM's agentic calibration is a pioneering demonstration of what that future looks like.”

The collaboration builds on existing integration between IQM and the NVIDIA quantum platform, including the NVIDIA NVQLink GPU-QPU hardware interconnect and NVIDIA CUDA-Q hybrid quantum-classical software platform.

For IQM, this advance is a proof point in its production quantum thesis. Central to that thesis is a commitment to open ecosystem development. IQM has consistently invested in open standards, partner integrations, and shared infrastructure — the conviction being that broad quantum adoption requires an ecosystem no single company can build alone.

IQM's open architecture, drawing on NVIDIA Ising open models for parallel agentic calibration is designed as a foundation enterprises can build on ahead of the fault-tolerant era. The quantum era does not begin when the technology works in a lab. It begins when institutions can own it, operate it, and build on it — without a team of quantum physicists running the infrastructure.

About IQM Quantum Computers

IQM Quantum Computers is a global leader in superconducting quantum computers, delivering full-stack quantum systems and cloud platform access to research institutions, universities, high-performance computing centres, and national laboratories worldwide. IQM's on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018, headquartered in Finland, it has over 350 employees. IQM operates across Europe, Asia, and North America and has announced its plans to become the first publicly listed European quantum company on a major U.S. stock exchange with a dual listing on the Helsinki Stock Exchange also under consideration.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414522140/en/

Contacts

Media contact:
Email: press@meetiqm.com
Mobile: +358 (0) 50 479 0845

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press Release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye